The traditional Indian medicine, also known as Ayurveda, has been used for thousands of years to treat a wide range of health conditions, including diabetes, arthritis, and respiratory problems.

Ayurvedic medicine treats the body, mind, and spirit using a holistic approach, and Ayurvedic practice uses essential herbs that have been revered for millennia and are now supported by a growing body of scientific evidence.

Researchers have found that several traditional medicines used in Ayurveda are effective in maintaining blood sugar levels in patients with Type 2 diabetes, and some herbs used in Ayurveda, such as turmeric, have been used for the treatment of diabetes in Ayurveda and traditional Chinese medicine.

The Indian government is documenting medicinal herbs of tribal communities across the country, and a pilot project in Uttarakhand has resulted in a five-volume book series documenting over 1,400 medicinal plants.

The National Institute of Pharmaceutical Education and Research has found three medicinal plants that can be combined to cure malaria, highlighting the potential of traditional Indian medicine in treating diseases.

The World Health Organization has established a centre in India to explore traditional medicine, with a focus on providing a reliable evidence base for policy and standards of traditional medicine practices and products.

The London School of Hygiene & Tropical Medicine is collaborating with the All India Institute of Ayurveda to research the effectiveness of a traditional Indian herb, Ashwagandha, in treating long Covid.

The study aims to determine whether Ashwagandha can help people recover from long Covid by reducing symptoms such as anxiety, stress, and fatigue, and will involve a double-blind clinical trial with 2,000 participants in the UK.

The Indian government is promoting the use of traditional medicine, including Ayurveda, Yoga, Unani, and Siddha, with a focus on research and development.

The Ministry of Ayush is working on scientific validation of traditional systems of medicine in India, including the development of vaccine platforms and the study of indigenous communities' knowledge.

The All India Institute of Ayurveda, National Institute of Unani Medicine, and National Institute of Homoeopathy are three national Ayush institutes that were inaugurated by Prime Minister Narendra Modi to promote research and education in traditional Indian medicine.

The Indian government has launched the "Heal in India" initiative, which aims to make India the number one choice for patients who wish to seek medical treatment outside their home countries.

The initiative will provide patients with quality service providers for each aspect of their treatment, including finding hospitals, certified facilitators, getting visa and forex options, assistance at airports, and post-treatment telemedicine.

The Central Drugs Standard Control Organisation (CDSCO) is the country's drug regulator, responsible for ensuring the safety and efficacy of traditional Indian medicine products for public use.

The CDSCO takes action in response to concerns raised by foreign regulatory agencies, such as the US FDA, to ensure the safety and efficacy of products manufactured in India.

The regulatory framework for traditional Indian medicine products is complex, and there are challenges in ensuring their safety and efficacy due to the lack of standardization and quality control.

The Indian government has taken steps to promote the use of generic drugs and to regulate the pharmaceutical industry, but more needs to be done to address the challenges in this area.

The CDSCO conducts monthly quality tests on drug samples from manufacturers across the country, and declares them substandard if they fail the test.

The state government has taken legal action against more than 40 drug companies, mostly located in Baddi, Kala Amb, and Paonta Sahib, for producing substandard drugs.

The government has identified improper storage and shipping of drugs as one of the reasons for the substandard quality of drugs.

The CDSCO has provisions for special approval for export of drugs against purchase orders placed by other countries, and can take action against companies found to be manufacturing contaminated drugs.

The current Drugs and Cosmetics Act has provisions for up to three-year imprisonment for violations, while a proposed Bill increases this to a minimum of 10 years.

The Parliamentary standing committee on health and family welfare has recommended having a separate legislation for medical devices.

The committee has suggested creating a new department for medical devices under the health ministry, namely the Department of Medical Devices.

The medical device industry has requested a separate Medical Devices Act, different from the one meant for regulation of Drugs.

The industry has stressed on the need to treat the regulatory framework for medical devices as a separate legislative book from drugs.

References: [1], [2], [3], [4], [5], [6], [7], [8], [9], [10], [11], [12], [13], [14], [15], [16], [17], [18], [19], [20], [21], [22], [23], [24], [25], [26], [27], [28], [29], [30], [31], [32], [33], [34], [35], [36], [37], [38], [39], [40], [41], [42], [43], [44], [45], [46], [47], [48], [49], [50], [51], [52], [53], [54], [55], [56], [57],.

The traditional Indian medicine, also known as Ayurveda, has been used for thousands of years to treat a wide range of health conditions, including diabetes, arthritis, and respiratory problems.

Title:

Content: News

Take up pilot project on Ayurveda treatment: MLA Ramdas

August 29, 2022

Mysore/Mysuru: Studies conducted across the world have found that several traditional medicines commonly used in India as part of Ayurveda are effective in maintaining blood sugar levels in patients with Type 2 diabetes.

Ayurveda is a traditional medical system that has been used for thousands of years in India and some of the herbs included are also used in other parts of the world. In this direction, a systematic project must be developed to treat diabetes, suggested MLA S.A. Ramdas. The suggestion was accepted by Ayurveda practitioners and experts in the field.

The MLA was speaking after inaugurating a free Ayurvedic treatment camp organised at the Sri Ganapathy Ashram on Nanjangud Road yesterday. The camp was organised inside the auditorium of Lakshminarasimha Kuteera of the Ashram by the Government Ayurvedic Research Centre and Ayurveda Academy of Chamarajpet in Bengaluru.

Ramdas suggested the doctors and officers launch a pilot project in a particular locality or a Ward and assured of making all facilities on behalf of the Government. He said that the project can be taken up on Sept. 17, the birthday of Prime Minister Narendra Modi for one year to achieve tangible results for the target population, he suggested.

Modern diabetes drugs are known for side effects and toxicity while Ayurveda works by controlling blood sugar and limiting the harmful effects of other drugs. Turmeric, for example, has been used for the treatment of diabetes in Ayurveda and traditional Chinese medicine, he added.

He said new Ayurvedic remedies were still in great demand for treating diabetes because of the limited efficacy and undesirable side effects of current drugs. A multi-pronged and individualised approach must be used to manage health conditions such as lifestyle modification, Ayurvedic detoxifying and purifying therapies and Ayurvedic medicines containing plant, animal, or mineral-origin ingredients, he added.

University of Mysore Vice-Chancellor Prof. G. Hemantha Kumar, Assistant Director of Government Ayurvedic Research Centre Dr. Lakshminarayana Shenoy, Joint Secretary of Ayurveda Academy Dr. Prashanth Ghokale, Junior pontiff of Ganapathy Ashram Datta Vijayananda Theertha Swamiji and others were present.

ABOUT

Mysuru’s favorite and largest circulated English evening daily has kept the citizens of Mysuru informed and entertained since 1978. Over the past 41 years, Star of Mysore has been the newspaper that Mysureans reach for every evening to know about the happenings in Mysuru city. The newspaper has feature rich articles and dedicated pages targeted at readers across the demographic spectrum of Mysuru city. With a readership of over 2,50,000 Star of Mysore has been the best connection between it’s readers and their leaders; between advertisers and customers; between Mysuru and Mysureans.

CONTACT

Academy News Papers Private Limited, Publishers, Star of Mysore & Mysuru Mithra, 15-C, Industrial ‘A’ Layout, Bannimantap, Mysuru-570015. Phone no. – 0821 249 6520

To advertise on Star of Mysore, email us at

Print Editon: [email protected]
For News/Press Release: [email protected]

In what areas have the medical uses of traditional Indian medicine been studied?

Treatment on diabetes
Treatment on arthritis

What does Berberine, a commonly used herbal material in traditional Indian medicine, treat?

What does traditional Indian medicine generally treat?

It addresses the physical aspects of health conditions.

What is the traditional Indian medical system called?

Ayurvedic medicine treats the body, mind, and spirit using a holistic approach, and Ayurvedic practice uses essential herbs that have been revered for millennia and are now supported by a growing body of scientific evidence.

Title:

Content: Healthy Directions Partners with Dr. Kulreet Chaudhary to Combine the Tradition Of Ayurvedic Practice with Modern-Day Science

Bethesda, Maryland, UNITED STATES

BETHESDA, M.d., March 14, 2023 (GLOBE NEWSWIRE) -- In Ayurvedic medicine, the body, mind and spirit are treated using a holistic approach. Part of the practice is the use of essential herbs that have been revered for millennia, and are now supported by a growing body of scientific evidence. This pairing of traditional use with clinical science creates uniquely modern Ayurvedic blends that can serve as a bridge to a new world of health and vitality. This is the motivation for neurologist and Ayurvedic practitioner, Dr. Kulreet Chaudhary’s development of Prajna Ayurveda herbals with Healthy Directions, which she says have a remarkable ability to reset and restore the body and mind.

Integrating traditional Ayurvedic practices and modern-day science has been Chaudhary’s method for decades and has helped her successfully restore thousands of patients back to health, as well as transform her own health. Partnering with Healthy Directions, an established 30-year-old manufacturer and marketer of doctor-formulated nutritional supplements, has empowered Chaudhary to develop herbal formulas made with powder from the whole plant, as it has been used for thousands of years, along with powerful extracts of the plant that have been clinically researched for specific health benefits.

“What impresses me about Healthy Directions is how well developed they are as a company in terms of the mind and the heart, and particularly the heart,” said Chaudhary. “The heart is the source of all healing in Ayurveda, so for me, it was so important to make a decision to partner with people who I know are heart-centered, and who really care about their customers.”

The literal meaning of Prajna (Praw-g-ńa) is “transcendental wisdom,” which in Ayurveda refers to the peace and balance that comes from being fully present in your body and mind. Chaudhary says it is the ultimate expression of wellness. There are four essential herbs that make up the foundation of all the Prajna Ayurveda formulas. These herbs are among Ayurveda's most trusted herbal medicines, that Chaudhary says can bring about transformational shifts in your physical health and overall well-being:

  • Prajna® Triphala is taken at night to cleanse and “sweep” the day away. This lesser-known herb has been traditionally used to support digestion and elimination, while also nourishing both mind and body for the day ahead.
  • Prajna® Ashwagandha is a popular “multi-tasker” herb that brings daily harmony, calm, and positivity by helping balance hormones and reducing levels of cortisol—the body’s primary stress hormone.
  • Prajna® Brahmi has been used by Ayurvedic practitioners for centuries as a tonic for overall mind and memory support as well as for its calming effects on the nervous system.
  • Prajna® Guggul is a purifying Ayurvedic herb traditionally used for its cleansing effects and to support a healthy inflammatory response and cholesterol health.

The Prajna Ayurveda herbs by Healthy Directions are responsibly sourced in India, blended traditionally, produced in vegan capsules, triple-tested to assure quality, purity and potency and contain no hidden allergens such as gluten, dairy, egg or soy. Each affordably priced product is balanced for use by all three Ayurvedic mind-body dosha types, and incorporates Ayurvedic healing practices of sound medicine and sacred geometry. As part of the Prajna Ayurveda product line, Chaudhary has also developed the Veda Wellness products that uses essential Ayurvedic herbs with clinically-studied ingredients for modern-day health concerns, including: Veda Rescue, Veda Lean, Veda Balance Brain and Veda Balance Gut to target specific health concerns. Learn more about Dr. Kulreet Chaudhary’s Prajna Ayurveda herb line and “Om Namo Narayani” (I honor the divine energy that resides in all of us) at: https://www.healthydirections.com/dr-kulreet-chaudhary.

About Healthy Directions: Healthy Directions LLC, a subsidiary of Wellful LLC, is a leading provider of premier doctor-formulated nutritional supplements and skincare products. Celebrating 30 years of providing expert natural health guidance from some of America’s most knowledgeable and highly respected integrative and alternative health doctors, including Dr. Julian Whitaker; Dr. David Williams; Dr. Stephen Sinatra; Dr. Drew Sinatra; Dr. Briana Sinatra; Dr. Kulreet Chaudhary, Dr. Rudrani Banik, Dr. Ken Redcross and Dr. Joseph Pergolizzi, Jr. Learn more at: https://www.healthydirections.com/about-us.

Photos accompanying this announcement are available at

https://www.globenewswire.com/NewsRoom/AttachmentNg/98eaae2d-7655-49e2-8ebd-2000394a053c

https://www.globenewswire.com/NewsRoom/AttachmentNg/e9e36fb5-0a2e-42a6-8d78-1913fc824c89

https://www.globenewswire.com/NewsRoom/AttachmentNg/52092125-bbf1-42f1-8678-9e0095707325

Video accompanying this announcement is available at

https://www.globenewswire.com/NewsRoom/AttachmentNg/aa418877-d78d-4fd7-a636-9f85666f0d55

Contact Data

What does traditional Indian medicine generally treat?

What is the traditional Indian medical system called?

What mental health problems does traditional Indian medicine treat?

Support the management of symptoms related to mental health.

What treatment did Former Kenyan President's daughter Rosemary Odinga get that helped her regain eyesight?

Traditional Indian medicine Ayurvedic treatment.

Researchers have found that several traditional medicines used in Ayurveda are effective in maintaining blood sugar levels in patients with Type 2 diabetes, and some herbs used in Ayurveda, such as turmeric, have been used for the treatment of diabetes in Ayurveda and traditional Chinese medicine.

How is traditional Indian medicine compared with traditional Chiese medicine?

In what areas have the medical uses of traditional Indian medicine been studied?

What does traditional Indian medicine generally treat?

It addresses the physical aspects of health conditions.

The Indian government is documenting medicinal herbs of tribal communities across the country, and a pilot project in Uttarakhand has resulted in a five-volume book series documenting over 1,400 medicinal plants.

Title:

Content: Govt to document medicinal herbs of tribal communities

Centre to document medicinal herbs of tribal communities across country

The union ministry of tribal affairs carried out the initiative in Kerala, Rajasthan, Maharashtra as well as in Uttarakhand

The Centre is working on documenting medicinal herbs and healers of the tribal communities across the country. A pilot from Uttarakhand has been completed, resulting in a five-volume book series of over 1,400 medicinal plants. The exercise, officials said, will be carried out in more states.

The union ministry of tribal affairs carried out the initiative in Kerala, Rajasthan, Maharashtra as well as in Uttarakhand. Apart from documenting the plant and healers, they also documented the Sanskrit names of these plants.

In Kerala, the Amrita Vishwa Vidyapeetham was given the responsibility, All India Institute of Medical Studies Jodhpur in Rajasthan, Pravara Institute of Medical Sciences Ahmedabad for Maharashtra, and Patanjali carried it out in Uttarakhand.

While the others are carrying it out, Patanjali’s series of seven tomes are ready. In the hill state three districts were chosen, which included Pithoragarh and Udham Singh Nagar, all phytodiversity was documented by a team of over 50-50 people over a period of two years.

When asked about the Sanskrit nomenclature, the official said that it was a way of directing attention to the functionality of the plant.

“The National Medicinal Plant Board says there are over 1,500 plants in Uttarakhand, many of which are not even documented. But in three districts alone, we found 900 plants,” a senior official of the ministry said. “Tribal medicine holds considerable interest among researchers.”

Chemical analysis of all these plants was carried out, to find the active ingredient in the plant, with the help of an HPLC machine, officials said. Apart from that, samples of these were preserved, along with data on their therapeutic use. The official said that permissions from the biodiversity board were also taken.

In addition to that, the Hyderabad-based National Institute of Pharmaceutical Education and Research (NIPER) carried out a similar exercise in their areas where they found three medicinal plants, which when combined can be a cure for malaria. A similar exercise was carried out by the same team in the Rashtrapati Bhawan as well.

Healers in tribal communities in the areas that use these plants were also documented, along with data of their areas of expertise. In all, 750 healers were documented.

Officials said that after the successful pilot, the ministry has sent it to the AYUSH ministry, urging them to take it further across the country using SC/ST components from their funds. Officials also said that details of these plants will be put up online.

Check out DH's latest videos

Check out DH's latest videos

Get a round-up of the day's top stories in your inbox

Check out all newsletters

Get a round-up of the day's top stories in your inbox

The National Institute of Pharmaceutical Education and Research has found three medicinal plants that can be combined to cure malaria, highlighting the potential of traditional Indian medicine in treating diseases.

The World Health Organization has established a centre in India to explore traditional medicine, with a focus on providing a reliable evidence base for policy and standards of traditional medicine practices and products.

Title:

Content: Archive / Lifestyle
The World Health Organization is interested in alternative medicine.
Mohamed Ismail - Cairo - DPA -
Many people use traditional medicine – but what do these methods really do?
A new WHO centre intends to explore this.
The center is based in India, a country where alternative medicine is so important that it even has its own ministry – which specializes in Ayurveda, Yoga, Physiotherapy, Greek Medicine, Master and Homeopathy.
Indian Prime Minister Narendra Modi attended the opening of the centre in Jamnagar in mid-April, saying: “India ’ s traditional medicine system is not just a cure.
It ’ s a comprehensive science of life. ”
According to the World Health Organization (WHO), the Indian government is supporting the centre with US $250 million (230 million euros).
WHO President Tedros Adhanom Ghebreyesus said: “The center aims to be an engine of innovation, moving towards an agenda of evidence, data and sustainability in traditional medicine, ” adding that the center would connect traditional medicine practitioners around the world and help set standards for research.
Traditional medicine is a broad field.
According to the World Health Organization ’ s statement for the center, 80% of the world ’ s population uses traditional medicine, which includes among other things acupuncture, Ayurvedic medicine and herbal blends.
Traditional medicine is also represented in modern science.
According to the World Health Organization, about 40% of all drugs approved today are derived from natural substances.
The discovery of aspirin, for example, is based on ancient recipes made from the bark of the willow tree.
The research for artemisinin for use in the fight against malaria, for which the Nobel Prize was awarded in 2015, began with the study of ancient texts of Chinese medicine.
George Rochmeyer of Cochrane, an international network that provides the scientific basis for decisions in the health field, said it makes sense at least to take a closer look at treatment methods that have been developed over centuries, to verify the reasonableness of these methods, and to conduct clinical studies on them in case of doubt.
Cochrane reviews are systematic reviews that collect all scientific evidence on a specific issue from medicine or other health sciences.
However, Rochmeyer also stressed that besides the examples of traditional methods cited by the WHO, which form the basis of currently developed treatments, there are likely many other examples where traditional methods of careful review have proven ineffective or even dangerous, such as phlebotomy, noting that spending too much money on studies to review a therapeutic practice is always a matter of discretion.
Rochmeyer stated that there are many Cochrane reviews about the use of traditional methods such as acupuncture in certain cases, but: “From my personal experience at Cochrane, I would say that I have not come across many reviews that have shown really compelling evidence for traditional therapeutic practice. ”
This is often due to the fact that when searching for these treatments we find only a few often-poorly conducted studies that cannot prove or disprove any benefit from them – which brings us back to the question of whether the already limited research funds should be invested in a scientifically unreasonable procedure – for example, homeopathy.
Professor Emeritus Edzard Ernst, a longtime professor of alternative medicine at the University of Exeter, noted that while it was necessary to wait and see who would lead the center and what it would do, the WHO press release was full of exaggerations.
The World Health Organization says it also wants to use new technologies at the new center for the study of traditional medicine — via artificial intelligence and big data, for example.
The center is expected to focus on providing a reliable evidence base for policy and standards of traditional medicine practices and products.
In addition, the center is supposed to help countries integrate these practices into their health systems.
You may also read.

What is the World Health Organization doing to promote traditional medicine, including Ayurveda?

Gathering evidence and data to guide policies

Establishing rules for the safe, fair, and effective use of traditional medicine

The London School of Hygiene & Tropical Medicine is collaborating with the All India Institute of Ayurveda to research the effectiveness of a traditional Indian herb, Ashwagandha, in treating long Covid.

Title:

Content: Tuesday 10 August 2021 1:10 pm

Long Covid cure? Researchers to trial traditional Indian herb treatment

The London School of Hygiene & Tropical Medicine will work with the All India Institute of Ayurveda to determine whether a traditional Indian herb can help people recover from long Covid.

Ashwagandha, commonly known as Indian winter cherry, is traditionally used in the Indian Ayurvedic system of medicine to boost energy, reduce stress and strengthen the immune system.

Experts said recent trials had proven the herb’s efficacy in reducing anxiety, stress, improving muscle strength and reducing fatigue symptoms in patients with chronic diseases.

Long Covid patients can suffer from cognitive dysfunction, poor mental health, extreme fatigue and muscle weakness.

It is estimated these symptoms affect 10 to 20 per cent of Covid survivors and can last for one to three months or longer in many cases.

The study, funded by the Ministry of Ayush of the Government of India, will include a double-blind clinical trial involving 2,000 people living in the UK with long Covid.

Half of the trial participants will take 500mg Ashwagandha tablets twice a day for three months, while the other half will be given a placebo.

Researchers will randomly select participants to have a monthly follow-up of self-reported quality of life, impairment to activities of daily living, mental and physical health symptoms, supplement use and adverse events.

The study is expected to last for over a year.

“Ashwagandha has been shown to reduce symptoms of other conditions that are similar to those of long Covid, so we are hopeful that it will be an effective way to combat the condition,” said Sanjay Kinra, professor in clinical epidemiology at the London School of Hygiene & Tropical Medicine.

The research is also supported by the UK’s All-Party Parliamentary Group on Indian Traditional Sciences and the Traditional Complementary and Integrative Medicine Unit at the World Health Organisation (WHO).

Research is the only way to ensure appropriate integration of traditional medicine knowledge into mainstream medical practice,” said technical officer at WHO Geneva, Geetha Krishnan, who helped to facilitate the research project.

Share

What is the traditional Indian medical system called?

The study aims to determine whether Ashwagandha can help people recover from long Covid by reducing symptoms such as anxiety, stress, and fatigue, and will involve a double-blind clinical trial with 2,000 participants in the UK.

In what areas have the medical uses of traditional Indian medicine been studied?

What mental health problems does traditional Indian medicine treat?

Support the management of symptoms related to mental health.

The Indian government is promoting the use of traditional medicine, including Ayurveda, Yoga, Unani, and Siddha, with a focus on research and development.

Title:

Content: News
News

M&A

Feature
Feature

Medical Specialties
Medical Specialties

Data & Analytics
Data & Analytics

Brand Solutions
Brand Solutions

View Site

G20 science advisors to discuss pre-competitive collaboration, traditional knowledge

Once it reaches a certain level of maturity, of course different countries will have their take. But pre-competitive R&D (research and development) space is what we think should be something where we should work:

New Delhi: In a bid to bolster the fight against future pandemics, India's top scientific advisor Prof Ajay Kumar Sood has urged G20 countries to collaborate in developing vaccine platforms by cooperating with each other in the pre-competitive research and development phase.

In a video interview Sood, who will chair the Chief Scientific Advisors' Roundtable (CSAR) of G20 countries next week, said India will also present its traditional systems of medicine and seek to harness the knowledge of indigenous communities of different countries.

Making a strong pitch for collaboration among G20 nations in drug development, Sood, the principal scientific advisor to the government, said there is enormous scope for cooperation in the pre-competitive research and development space.

"Once it reaches a certain level of maturity, of course different countries will have their take. But pre-competitive R&D (research and development) space is what we think should be something where we should work," he said.

Sood identified emerging technologies for environmental surveillance as another area for cooperation.

"This is something which has to be done by all countries. A lot of it is happening but there are many other countries which will need a helping hand. So, we should be ready to take everyone along," he said.

Pre-competitive collaboration involves two or more companies operating within the same industry coming together to address a shared problem or pain point that doesn't impact direct business competition or contribute to unfair advantage.

"When there is a pandemic, you cannot live in isolation. We have seen it in COVID, all countries will have to fight it together and it has to be eradicated or controlled at all places. If it does not, then it will linger on and that is what you are seeing for COVID," Sood said.

He said the CSAR meeting in Uttarakhand's Ramnagar from March 28-30 will also focus on harnessing the benefits of traditional knowledge in healthcare.

"Traditional medicine has a very important role to play but it should be put in scientific context. All that work has to be done. When you have traditional medicines, how can we put it on a platform where it meets the acceptance of science," he said.

Sood said India has a very rich tradition of Ayurveda, Siddha and Unani and all of them have a role to play. It could be to build up immunity or strength or to address the symptoms of a disease, adding " whatever you think, it is possible".

"We should not try to limit ourselves to only what we call modern medicine," he said, making a strong pitch for diversity in various systems of medicine.

Sood also talked about harnessing the knowledge repositories of indigenous communities in G20 countries for the benefit of humankind.

"These are very, very old traditions. The goal should be, what we call traditional knowledge, it is really tested over centuries. It is very important that we take this traditional knowledge along with the other streams," Sood said.

Sood said the Ayush ministry is working on scientific validation of traditional systems of medicine.

"The Ayush ministry is doing that. This word was coined a few years back ayurvedic biology to address the issue of scientific validity. I am sure that in other countries there are parallel efforts. Because these tribal, traditional things are also very important and we need to learn from them," Sood said.

The three-day meeting in Ramnagar will focus on four broad themes Opportunities in One Health for better disease control and pandemic preparedness; Synergising global efforts to expand the access to scholarly scientific knowledge; Diversity, equity, inclusion and accessibility in science and technology (S&T); and an Institutional mechanism for inclusive, continuous and action-oriented global S&T policy dialogue.

Get latest Industry insights and analysis in your inbox

Learn from updates & industry leaders Daily.

Great, We will keep you updated

Download our App for Realtime updates

Download App

Follow and connect with us on , Facebook, Linkedin, Youtube
Partners:

The Ministry of Ayush is working on scientific validation of traditional systems of medicine in India, including the development of vaccine platforms and the study of indigenous communities' knowledge.

The All India Institute of Ayurveda, National Institute of Unani Medicine, and National Institute of Homoeopathy are three national Ayush institutes that were inaugurated by Prime Minister Narendra Modi to promote research and education in traditional Indian medicine.

Title:

Content: Three National Ayush institutes inaugurated by Prime Minister Narendra Modi

New Delhi : The nation today got three National Ayush Institutes of eminence in Ayurveda, Homoeopathy and Unani. Prime Minister Shri Narendra Modi today virtually inaugurated All India Institute of Ayurveda in Goa, National Institute of Unani Medicine in Ghaziabad, and National Institute of Homoeopathy at Delhi from Goa.

The Prime Minister was participating in the valedictory ceremony of the 9th World Ayurveda Congress (WAC) at Panjim, Goa. The four days deliberation at 9th WAC provided a global platform for national and global stakeholders, industry leaders, practitioners, traditional healers, educationists, and manufacturers for engaging in intellectual exchange to strengthen the Ayurveda sector.

The valedictory ceremony was attended by Shri P. S Sreedharan Pillai, Governor of Goa, Shri Pramod Sawant, Chief Minister, Goa, Shri Sarbananda Sonowal, Union Cabinet Minister of Ayush and Ports, Shipping & Waterways and Dr. Munjpara Mahendrabhai, Minister of State for Ayush and Women & Child Development. Shripad Yesso Naik, Minister of State for Tourism and Ports, Shipping and Waterways and President, Vijnana Bharati and others were also present.

Addressing the gathering Prime Minister Shri Narendra Modi, said, “We need to continuously work toward the documentation of ‘Data Based Evidence’, we had Ayurveda’s results as well as effects in our favour, but we were lagging behind in terms of evidence. He emphasized that our medical data, research, and journals have to be brought together to verify every claim on modern scientific parameters.”

He added that more than 30 countries have recognized Ayurveda as a traditional medicine system and we have to further promote Ayurveda in every country of the world. PM emphasized that Ayurveda is not just about treatment, it also promotes wellness. The world is now returning to our traditional medicine and Yoga and Ayurveda are the new hope for the world.

On this occasion, Shri Sarbananda Sonowal said, “Ayush Ministry is committed to imparting Ayush health systems into day to day life of the common man by strengthening systems in Health as well as the Education sectors to the people of India. We want Ayush system to become a part of every household not only in India but globally and are trying our best to fulfill dream of Heal in India.”

The Ayush Minister further added, “with the rapid strides in the Ayush sector, in India’s Azadi ka Amrit Kaal, I firmly believe that under the guidance of PM Shri Narendra Modi, it will certainly be ‘Ayush Ka Amrit Kaal’.

Shri Vijay Kumar Saxena, Lt. Governor, Govt of NCT was the chief guest at National Institute of Homoeopathy (NIH), Delhi. It is a first of its kind to be established in Northern India for developing the Homoeopathic system of medicine. General (Retd) V.K. Singh, Union MoS for Road Transport & Highways and Civil aviation was chief guest at National institute of Unani Medicine (NIUM), Ghaziabad.

Prime Minister also visited Arogya Expo held along with 9th WAC and keenly observed and interacted with participants of the Expo.  Various Ayush institutes and research councils, more than 215 companies, leading Ayurveda’s brands, medicine manufacturers and Ayurveda related educational and R&D institutions participated in the Arogya Expo.

The Indian government has launched the "Heal in India" initiative, which aims to make India the number one choice for patients who wish to seek medical treatment outside their home countries.

Title:

Content: you are here: HomeNewsTrends

MC Explains I What an initiative like Heal in India can achieve

India is already among the top draws for international patients. The initiative is looking to capture a much bigger pie of the global medical tourism sector, worth $80 billion

August 09, 2022 / 04:26 PM IST

Representative image: Reuters/Anushree Fadnavis

This Independence Day, Prime Minister Narendra Modi is likely to announce a major "Heal in India initiative", under which the government plans to take the medical tourism market, worth $6 billion in 2020, to $15 billion over the next four years. But how is India placed on the world tourism map and what all is it planning to be among the top draw for people with medical needs?

What’s the status of medical tourism in India now?

India is ranked 10th out of the top 46 countries in the Medical Tourism Index 2020-21 by the Medical Tourism Association. However, industry insiders like Danish Hasan of Healthtrip, a leading company that facilitates treatment for patients in India, say India stands at number three or four in terms of drawing the maximum number of foreigners every year for medical reasons.

Experts say the country’s dominance in the global medical tourism market, with its world-class healthcare facilities and exceptional medical expertise and traditional hospitality, is well recognised.

India, for instance, has more than 36 hospitals accredited by the Joint Commission International and over 600 hospitals accredited by the National Accreditation Board for Hospitals and Healthcare Providers.

Close

Industry insiders also say that time-tested healing practices such as Ayurveda have further augmented India’s market, offering international patients a great medical tourism and wellness experience. The Ayurveda industry in Kerala, mainly driven by foreigners, for example, is worth $2 billion.

Also read: Interview | India’s healthcare digitalisation needs bigger push for better impact

What does "Heal in India" hope to achieve?

A plan prepared by the Union health ministry on the initiative says the country has the potential to surpass all other nations and take the pole position as the medical value travel leader. The cost of treatment in India, for instance, is 50 percent of what it takes in Thailand and 20 percent when compared to Singapore.

Through the initiative, the government seeks to make India the number one choice for patients who wish to seek medical treatment outside their home countries.

Hasan said that the scheme will further organise the sector and its ecosystem and will significantly enhance patient confidence for availing treatment in India as they will have many grievance redressal options with the government.

“Government to government tie-ups will drive more patients to the country,” he said.

From finding hospitals to certified facilitators, getting visa and forex options, assistance at airports and post-treatment telemedicine, patients will get quality service providers for each aspect, Hasan said.

In AYUSH or the traditional stream of medicine, for example, patients will be able to discover and take services from certified centres with high-quality treatment, according to him.

Harsimarbir Singh, co-founder of health-tech platform Pristyn Care, said that the initiative is likely to ensure accessibility, affordability, transparency, and seamless clinical experience for international patients.

What are the components of the initiative?

There are about 70 countries from where patients come to India to seek treatment but the largest numbers are from 44 countries, which include SAARC nations, the Middle East and Africa. Patients from developed countries mostly come to India to seek wellness treatment, involving Ayurveda.

Also read: MC Exclusive | NMC seeks accreditation for global recognition of India’s medical colleges

Under the scheme, efforts will be launched to tap an even larger number of patients from countries from where maximum tourists arrive.

As part of the initiative, interpreters and special desks at 10 airports— Delhi, Mumbai, Chennai, Bengaluru, Kolkata, Visakhapatnam, Kochi, Ahmedabad, Hyderabad and Guwahati—and a multi-lingual portal and simplified visa norms are going to be put in place.

The portal will be launched specifically to guide medical tourists with details such as hospitals, details of treatment available and standardised rate cards. The health ministry has also identified nearly 40 hospitals across 12 states that will be offered assistance through the initiative.

In addition, the government is also looking to promote medical tourism in some government hospitals for the first time.

Government officials said that, currently, the fee for a medical visa is higher than the fee for a tourist or a business visa and requires more documentation.

“This discourages patients from applying for medical visas, and on many occasions, they travel on tourist visas but it makes medical treatment difficult for them—we want to change that,” the official said.

The Ministry of External Affairs is also considering opening missions in high potential African and Middle East countries while existing missions may run dedicated medical value travel desks, acting as a single stop for comprehensive information relating to partners, procedures, costs and visas.
Sumi Sukanya Dutta
first published: Aug 9, 2022 02:52 pm
Sections

The initiative will provide patients with quality service providers for each aspect of their treatment, including finding hospitals, certified facilitators, getting visa and forex options, assistance at airports, and post-treatment telemedicine.

The Central Drugs Standard Control Organisation (CDSCO) is the country's drug regulator, responsible for ensuring the safety and efficacy of traditional Indian medicine products for public use.

Title:

Content: Thursday, Oct 06, 2022

Syrups flagged by WHO not sold in India, only exported to Gambia: Govt

The manufacturers had been given special approval for export against purchase order placed by Gambia. “These drugs are not sold in India, so the company needed a special approval,” said an official investigating the matter.

Maiden Pharmaceuticals Limited factory in Sonepat district. (PTI Photo)

After an alert about four syrups was raised by World Health Organization (WHO) on Wednesday, Indian authorities investigating the matter said the sales of the particular products were limited to Gambia.

“These 04 drugs are not licensed for manufacture and sale in India. In effect, none of these four drugs is sold domestically,” said a release from the union health ministry.

The manufacturers had been given special approval for export against purchase order placed by Gambia. “These drugs are not sold in India, so the company needed a special approval,” said an official investigating the matter.

Following the death of 66 children in Gambia, the WHO has raised an alert for four India-manufactured fever, cough and cold syrups, urging people to not use them. All the four syrups — Promethazine Oral Solution, Kofexmalin Baby Cough Syrup, Makoff Baby Cough Syrup and Magrip N Cold Syrup — were manufactured by Haryana-based Maiden Pharmaceuticals.

Subscriber Only Stories

As per information sent to Indian authorities, the intra-government organisation tested 23 samples of the syrup of which four were found to contain di-ethylene glycol and ethylene glycol, which are toxic for humans and can lead to acute kidney injury and kidney failure in children.

The ministry also urged the WHO to share report on causal relationship — confirmation that the syrups led to the deaths in Gambia — at the earliest. A release from the union health ministry said: “The exact one-to-one causal relation of death has not yet been provided by WHO to CDSCO. As a robust National Regulatory Authority, CDSCO has requested WHO to share at the earliest with CDSCO the report on establishment of causal relation to death with the medical products in question.”

Action against the company

With the products not meant for Indian markets, there weren’t any market samples that could be tested by Indian authorities. A joint team of Central Drugs Standard Control Organisation and Haryana State drug regulator investigating the matter have lifted the controlled samples — samples from the batches sent to Gambia stored by the manufacturers as part of quality control procedures.

Advertisement

The samples have been sent to regional drug testing lab in Chandigarh. According to officials who are part of the investigation in India, even if the control samples are found to be contaminated, the authorities are unsure what action can be taken against the company.

“WHO has shared its findings, but we also have to see whether the control samples contain the contaminants in question. If we do find contaminants, proportionate action will be taken against the company, which may include suspension of the licence to export the drug. However, we are unsure whether we can initiate criminal action against the company because the deaths did not happen in India,” the official said.

The current Drugs and Cosmetics Act has provisions for up to three-year imprisonment, while the proposed Bill has increased this to a minimum of 10 years. In a release, the health ministry said: “It is a usual practice that the importing country tests these imported products on quality parameters and satisfies itself as to the quality of the products before the importing country decides to release such products for usage in the country.”

First published on: 07-10-2022 at 01:31:46 am
Next Story

Nearly half of work on Ayodhya Ram Mandir complete: Adityanath

Advertisement
Advertisement
Advertisement
Advertisement

The CDSCO takes action in response to concerns raised by foreign regulatory agencies, such as the US FDA, to ensure the safety and efficacy of products manufactured in India.

Title:

Content: Search
+
    The Economic Times daily newspaper is available online now.

    Global Pharma under CDSCO watch after USFDA curbs eyedrops imports

    Synopsis

    The Central Drugs Standards Control Organisation (CDSCO), the country's drug regulator, has sent a team of experts to inspect Chennai-based manufacturer Global Pharma Healthcare after the US Food and Drug Administration (FDA) restricted the import of eye drops manufactured by the company.

    The Central Drugs Standards Control Organisation (CDSCO), the country's drug regulator, has sent a team of experts to inspect Chennai-based manufacturer Global Pharma Healthcare after the US Food and Drug Administration (FDA) restricted the import of eye drops manufactured by the company. The FDA said the company's Artificial Tears brand of eyedrops were linked to multiple adverse events. "To date, there are 55 reports of adverse events, including eye infections, permanent loss of vision and a death with a bloodstream infection", the FDA said in a statement. The company has voluntarily recalled all the lots of the eyedrop due to possible contamination, the FDA said.

    Experts from DGCI are inspecting Global Pharma Healthcare's production facilities, and samples will be taken for further investigation, ET has been told by people aware of the developments.

    The products are not sold in India, the same people said.

    Global Pharma Healthcare said it is notifying distributors Aru Pharma Inc and Delsam Pharma, and requesting wholesalers and retailers to recall the product. Customers who have the purchased the product should stop using it, the company said in a statement. This recall is being conducted with the knowledge of the US Food and Drug Administration, it further said.

    Experience Your Economic Times Newspaper, The Digital Way!
    • Front Page
    • Pure Politics
    • Companies
    • Markets
    • More
      (Catch all the Business News, Breaking News Events and Latest News Updates on The Economic Times.)

      Download The Economic Times News App to get Daily Market Updates & Live Business News.

      ...more

      Stories you might be interested in

The regulatory framework for traditional Indian medicine products is complex, and there are challenges in ensuring their safety and efficacy due to the lack of standardization and quality control.

Title:

Content: 11 Himachal Pradesh drugs fail quality test, 74 found inferior in 3 years

Representative image
KULLU: The Central Drugs Standard Control Organisation (CDSCO) has declared the samples of 11 medicines made in Himachal Pradesh as substandard. Made in Baddi (Solan district), Kala Amb and Paonta Sahib (Sirmaur) and Sansarpur (Kangra), these drugs are used for treating clots, diabetes, bacterial infections, acid-related diseases and calcium deficiency.
The regulatory body tested 1,251 samples from across the country and found 59 not of standard quality. The drug control administration will recall all those drugs that failed the test. It has also issued a notice to the manufacturing companies. The CDSCO approves or bans drugs based on monthly clinical trials.
In CDSCO's alert for January, 16 drugs manufactured in Himachal were declared sub-standard, and in December 2022, 27 failed to clear the quality test.
Replying to MLA Vipin Singh Parmar's question in the budget session, the state government claimed that 74 local drugs had failed the quality test in three years. It claimed to have taken legal action against more than 40 drug companies, located mostly in Baddi, Kala Amb and Paonta Sahib.
Earlier, 32 local drugs had failed the quality test in 2020-21, and 20 and 22 in the following two fiscals. In most cases, the government suspended the product permission for up to 45 days, withdrew the stock and issued show-cause notices. Kala Amb's Nixi Laboratories, with 16 failed samples, which included anaesthetic Propofol, had to stop production. Five patients died last year on the operation table of the Post Graduate Institute of Medical Education and Research in Chandigarh after being injected with this drug.
The state government has counted 660 pharmaceutical companies in Himachal and sent their drug samples to the Composite Testing Laboratory at Kandaghat in Solan, Chandigarh's Regional Drug Testing Laboratory and Kolkata's Central Drugs Laboratory. Most of the substandard drugs had failed the Drugs and Cosmetics Act standard set up in 1940 and the Drugs and Cosmetics Rules laid down in 1945. The government also replied in the House that the companies had neither stored nor shipped the drugs properly.
Start a Conversation
FOLLOW US ON SOCIAL MEDIA
FacebookTwitterInstagramKOO APPYOUTUBE

The Indian government has taken steps to promote the use of generic drugs and to regulate the pharmaceutical industry, but more needs to be done to address the challenges in this area.

Title:

Content: Open App
Live: Bajar Gupshup
you are here: HomeNewsTrendsHealth

Doctor-Pharma Nexus Part II: What drives drug prescription in India?

If doctors are concerned about the quality of generic drugs and hesitate to prescribe them, how do they decide which medicines patients should take?

September 21, 2022 / 03:13 PM IST

Representative image

In September 2016, the Medical Council of India, the former regulator for medical professionals, amended the Indian Medical Council (Professional Conduct, Etiquette and Ethics) Regulations of 2002, asking doctors to prescribe generic drugs “as far as possible.”

“Every physician should, as far as possible, prescribe drugs with generic names legibly and preferably in capital letters and he/she shall ensure that there is a rational prescription and use of drugs,” it said in the new provision.

On April 17 the following year, Prime Minister Narendra Modi created a stir in the medical fraternity by indicating that a law may be introduced making it mandatory for doctors to prescribe medicines by their generic names.

Five days later, the MCI issued another advisory, asking doctors to follow the norms of prescribing generic medicines and adding that there would be provisions for disciplinary action against defaulters.

Of course, there is no parliament-backed law on this yet, nor an explanation on why it hasn’t happened. And it is common knowledge that hardly any doctor prescribes generic medicines to patients in India.

Close

The icing on the cake is that the MCI – replaced by the National Medical Commission three years ago – has never penalised a doctor for not prescribing generic medicines.

The regulations on the professional conduct of doctors also sought to suspend their licence to practice if found guilty of accepting gifts or freebies from pharmaceutical companies. However, any conviction on these charges is unheard of in the past 20 years.

What are the factors considered when a physician prescribes medicines to a patient? Many doctors and activists say it may have little to do with science.

Generic medicines

A drug that goes off-patent becomes a generic medicine and it could become available under an official international non-proprietary name (INPN) or a brand. The official name or INPN is the generic name of a medicine that is accepted worldwide but in India, one of the largest producers of generic drugs globally, these medicines are mostly in the form of branded generics.

Also Read I Pharma-Doctor Nexus Part I: Why rules, Code for doctors, drugmakers have failed to curb unethical practices

After the MCI’s directives on generic drugs, doctors raised queries about how the government could ensure the quality of such medicines, concerns that persist today.

Dr Rajeev Jayadevan, a clinician and medical researcher from Kerala who is also associated with the Indian Medical Association, said that from a doctor’s perspective, the basic objective while writing a prescription is for the patient to feel better and recover.

Unless the patient improves, the doctor’s practice becomes unsuccessful, he said, adding that unlike in western countries, not all medicines available in India are of uniformly high quality.

“Only a small fraction undergoes quality checks and numerous manufacturers are known to make the same medicine under different brands,” said Jayadevan. “Fake medication is also known to be widespread. This makes generic prescribing difficult.”

Brand is king

While quality concerns may prevent some doctors from prescribing generic medicines, the pharmaceutical industry in India is allowed to operate on the basis of aggressive brand marketing.

Under the product differentiation strategy, says Dr Arun Gadre, founding member of the Association of Doctors for Ethical Healthcare (ADEH), drugmakers change a product slightly to differentiate it from those of competitors.

The companies then deploy their medical representatives to tell doctors what’s different about the product and offer them inducements, commissions and incentives to suggest these drugs to patients, he alleged.

While medical representatives should be knowledgeable about studies conducted on a drug, its safety profile, and possible side-effects, and pass on such information to doctors, Gadre says they themselves are hardly aware of such matters.

“Their only role, as of today, is to literally promote the given brands and by promoting, we mean doing all the dirty work of the companies, which is to offer incentives and keep the doctors happy by any means,” said the gynaecologist who was part of a two-member team that conducted a detailed study on the pharma industry’s influence on doctors in 2019.

When contacted for comments, the Indian Pharmaceutical Alliance, a group of research-based drugmakers, meanwhile stressed that the pharmaceutical industry is one of the most regulated industries in India and follows all the regulations & guidelines.

The industry is governed by the Uniform Code of Pharmaceuticals Marketing Practices, it said, adding that the Code addresses communication based on scientific evidence about the product and the related marketing practices.

“The companies have set up systems and processes and further undertake training of employees in this regard,” IPA said in response to a query by Moneycontrol. “The Code prescribes a procedure for lodging and handling of a complaint. IPA has set up defined processes for handling the complaint, as required in the UCPMP."

A spokesperson for the Organisation of Pharmaceutical Producers in India (OPPI), a group of MNC pharma companies, said that its member companies are committed to following the highest ethical standards in their interaction with healthcare professionals, medical institutions, and patient organizations.

The companies follow the stringent OPPI Code of Pharmaceutical Practices 2019 that, though based on the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) Code, is well aligned to applicable ethical norms in India.

“OPPI applauds the efforts that the government is taking in building a stronger ethical framework in the country and will continue to partner with the government on the same,” said the spokesperson. “We support these steps being taken in the right direction.”

No response was received from Indian Drug Manufacturers’ Association.

But Gadre noted that the strategy adopted by drugmakers won’t work unless the medical fraternity is their partner in the process.

“It’s not a secret that there is a crisis of ethics in the medical community but another reason why they are a solid partner to pharma companies is because they are also not regulated very well,” he said.

Dr Gurinder Grewal, who is also attached with the ADEH, said a key problem is that pharma companies treat both doctors and patients as customers.

“Freebies are offered freely to doctors and though some understand that this may be unethical, the majority gets tempted,” he said.

Malini Aisola, co-convener of the All India Drug Action Network, a patient rights group, insisted that barring a few exceptions, most doctors readily accept gifts and freebies from drugmakers.

According to Gadre, the existing NMC code has major loopholes—apart from policing problems—that allow doctors to keep working hand-in-glove with drugmakers.

Unethical practices

“The code, for instance, allows a doctor to be on an advisory board of a pharma company and doctors’ associations to accept sponsorships from drugmakers in the name of continued medical education,” he said.

“These are some of the wide-gaping holes that provide tools to both pharma firms and doctors to exist in a perfect symbiotic relationship which is often not ethical. And then no one has ever heard of any doctor being penalised for accepting a bribe, gift or freebie.”

Former IMA president Ravi Wankhedkar agreed that as is the case with other laws in the country, implementation of the professional code of conduct for doctors remains poor.

“There should be some mechanism in place to strengthen it,” he demanded.

All this, said Wankhedkar, may be part of the larger problem that arises out of the privatisation of medical education, peer pressure, and cutthroat competition among specialists and super specialists in urban areas in the backdrop of sliding incomes, pushing some doctors towards unethical practices.

Also Read I Cancer treatment costs: Little respite from new list of essential drugs

Email queries sent to NMC chairman Dr Suresh Chandra Sharma and Dr Achal Gulati, president of the commission’s Ethical and Medical Regulation Board, seeking their comments on how the loopholes are being plugged and their views on implementation of regulations were unanswered.

However, a member of the commission who did not wish to be identified, said there were very few complaints against doctors and pharma companies with specific details.

“We keep getting generic complaints from public representatives such as members of Parliament that doctors do not prescribe generic drugs or that they take freebies from drugmakers, but where are the complaints from patients?” the member asked.

According to the member, there have been 2-3 complaints over the past few years of this nature but follow-ups have been difficult for want of evidence.

“In the case of freebies, a giver and a receiver are involved with hardly any evidence to prove wrongdoing—there is little that can be done in such cases,” the member said.

The commission is preparing a new version of the code of conduct for doctors and a draft was released for public feedback in May. However, this version too does not seem to have addressed the many loopholes that activist doctors such as Gadre have highlighted.

Drug regulator, where art thou?

Gadre pointed out that it is the job of the regulator to periodically make available scientific data on the medicines based on which doctors should or should not prescribe a drug.

For example, there are many brands of paracetamol, a drug commonly used for the treatment of fever and pain. How does one deduce that paracetamol made by company A is better than paracetamol by company B? It’s a tricky question to manoeuvre for even honest medical practitioners.

This is especially important as the process of drug approval in India often does not inspire confidence.

“Due to the lack of scientific details – in the form of post-marketing surveillance data on medicines – doctors are trapped with only three options: their own belief based mostly on feedback from patients, choice of a low-cost brand, or influence by the drugmaker,” said Gadre. “Sadly, none of these is a rationale or scientific way to prescribe a medicine.”

While it may be impossible to publish the details and data of every brand, what the Central Drugs Standard Control Organisation can do, based on inputs from state food and drug administrators, is carry out periodic sampling exercises and publish the details publicly.

Moneycontrol reached out the CDSCO chief, Drug Controller General of India VG Somani, for his comments on the matter, but did not receive any reply.

Meanwhile, experts said there may be ample room for CDSCO to do better.

Also Read I Do regulators approve non-cancer drugs easily in India? Study suggests so

“As per the norms, pharma companies are required to submit post-marketing surveillance data on every drug to the regulator for a minimum of four years,” said senior pharmacologist Santanu Tripathi, who has previously served on some CDSCO panels. “But it’s only the CDSCO which can tell whether that data is received from companies or released for the benefit of doctors.”

Sumi Sukanya Dutta
Sections

The CDSCO conducts monthly quality tests on drug samples from manufacturers across the country, and declares them substandard if they fail the test.

Title:

Content: Made-in-Himachal Pradesh drug samples fail quality test; max from Baddi

22 drugs manufacturers in Himachal Pradesh failed the quality test by CDSCO for sub-standard drugs like Zee Laboratories and Daxin Pharmaceuticals.
SHIMLA: As many as 22 drugs manufacturers in Himachal Pradesh have failed the quality test run by the Central Drugs Standard Control Organisation (CDSCO). In an alert issued for the month of May, the CDSCO has declared the drug samples to be of sub-standard quality. Of the total failed drug samples, 16 have been manufactured at Baddi in Solan, 5 in Paonta Sahib and Kala Amb in Sirmaur and 1 in Una.The drugs are used for treating ailments including throat infection, high blood pressure, cancer, infections, ulcer, cough, acidity and fever etc.
As per the CDSCO alert, three samples of Zee Laboratories, a pharma unit based in Paonta Sahib, and two samples of Baddi-based Daxin Pharmaceuticals, have failed quality test. A total 52 samples from all over the country have been declared to be of sub-standard quality by the CDSCO, a central drug regulatory body that approves and bans drugs and also conducts monthly clinical trials to test the quality of drugs. As per the state’s Drug Control Administration (DCA), the drugs whose samples failed would be withdrawn from the markets and manufacturers would be issued notices. Since January this year, 55 drug samples have failed the CDSCO drug quality test. Last month in April, 6 drugs manufactured in Himachal Pradesh failed the CDSCO quality test, 20 drugs in March, 21 in February and 14 in January.
In 2023, as many as 120 drugs, manufactured in Himachal Pradesh, had failed the CDSCO test. There are a total 660 pharmaceutical companies based in Himachal Pradesh with majority of them in Baddi, which is one of the biggest pharma hubs of the country. Along with CDSCO, drug samples are sent for testing to the Composite Testing Laboratory, Kandaghat in Solan and Regional Drug Testing Laboratory, Chandigarh. tnn
We also published the following articles recently

AstraZeneca's breast cancer drug fails in late-stage trial test
AstraZeneca's breast cancer drug Truqap failed to meet main goals in late-stage trial for metastatic triple-negative breast cancer patients.
Properties of drug peddlers to be frozen within week: CM
Punjab CM Bhagwant Mann unveils strategy to dismantle drug trade nexus with police reforms. Officers involved to face dismissal and property freezing. Thousands of police transfers made to break nexus.
Nagpur hit-&-run: Cop benched for 48-hr delay in sending blood samples for test
Nagpur police commissioner suspends senior inspector for delay in sending blood samples of hit-and-run case accused for alcohol testing after car accident kills two and injures 15 near Dighori toll naka.
End of Article
FOLLOW US ON SOCIAL MEDIA

The state government has taken legal action against more than 40 drug companies, mostly located in Baddi, Kala Amb, and Paonta Sahib, for producing substandard drugs.

The government has identified improper storage and shipping of drugs as one of the reasons for the substandard quality of drugs.

The CDSCO has provisions for special approval for export of drugs against purchase orders placed by other countries, and can take action against companies found to be manufacturing contaminated drugs.

The current Drugs and Cosmetics Act has provisions for up to three-year imprisonment for violations, while a proposed Bill increases this to a minimum of 10 years.

The Parliamentary standing committee on health and family welfare has recommended having a separate legislation for medical devices.

Title:

Content: Parliamentary committee recommends a separate medical devices Bill

According to sources, DCGI has convened a meeting in Delhi on August 10 to discuss matters related to the draft New Drugs, Medical Devices and Cosmetics Bill, 2023

Sohini Das Mumbai

Listen to This Article

Amid a tussle between the medical device makers lobby and the Centre, the Parliamentary standing committee on health and family welfare has recommended having a separate legislation for medical devices and also a new department for medical devices under the health ministry.

According to sources, the Drugs Controller General of India (DCGI) has convened a meeting in Delhi on August 10 to discuss matters related to the draft New Drugs, Medical Devices and Cosmetics Bill, 2023.

The panel said in a report tabled in the House on August 4 that “instead of bringing a combined legislation for drugs, medical devices and cosmetics, the ministry should formulate a separate legislation for medical devices and create a new department, namely the Department of Medical Devices”.

It felt that to have a “world-class regulatory framework”, boost the medical device industry, and minimise dependency on imports, a separate department and separate legislation is required. “… the committee feels that though both are medical products but the medical devices are not pharmaceuticals,” the report said.

“The committee has observed that in recent years the indigenous medical industry is growing fast and to match with the pace existing drug inspectors (medical devices) and medical device officers working under the CDSCO would not be able to cater the needs of the industry. Therefore, a separate regulatory infrastructure for medical devices with dedicated work force instead of adjoining with the CDSCO would serve the purpose better,” it said.

Last week, medical device makers, patient interest groups, hospitals among others had written to the Union Health Minister Mansukh Mandaviya seeking a separate Bill for medical devices distinct from drugs, and also recall the draft New Drugs, Medical Devices and Cosmetics Bill, 2023 that is likely to be tabled in the monsoon session.

Also Read

Industry, patient groups want draft drugs and medical devices Bill recalled

Pocket-friendly health: Price caps on critical medical devices extended

Clear final MBBS exam in 2 attempts: SC to foreign return medical students

What is new medical registration system and why doctors are concerned?

Uttar Pradesh govt looking to tap domestic medical devices' market

Govt moves Bill in Rajya Sabha dropping CJI from selection process of EC

RBI to prescribe framework to reset floating interest rate loans

RBI likely to seek comfort around Rs 1 trillion surplus liquidity

GBA: India reaching out to non-G-20 members before September summit

Rural volumes grow for second straight quarter in 2023, shows NIQ data

In a joint plea, the Association of the Indian Medical Devices Industry (AiMeD) has requested the health minister to recall the new draft Bill, stating that the Bill, if passed, would push the sector into a “supply chain crisis” and would “effectively lose its ability to meet domestic demand”.

Sources said the stakeholders met government officials on Wednesday to discuss the matter.

The associations have demanded a separate Medical Devices Act, different from the one meant for regulation of Drugs and also stressed on the need to treat regulatory framework for medical devices as a separate legislative book from drugs. This has been a long-standing demand from the industry.

First Published: Aug 10 2023 | 9:15 PM IST

Explore News

The committee has suggested creating a new department for medical devices under the health ministry, namely the Department of Medical Devices.

The medical device industry has requested a separate Medical Devices Act, different from the one meant for regulation of Drugs.

The industry has stressed on the need to treat the regulatory framework for medical devices as a separate legislative book from drugs.

References: [1], [2], [3], [4], [5], [6], [7], [8], [9], [10], [11], [12], [13], [14], [15], [16], [17], [18], [19], [20], [21], [22], [23], [24], [25], [26], [27], [28], [29], [30], [31], [32], [33], [34], [35], [36], [37], [38], [39], [40], [41], [42], [43], [44], [45], [46], [47], [48], [49], [50], [51], [52], [53], [54], [55], [56], [57],.


The Little Mermaid statue in Copenhagen has been vandalized multiple times since its installation in 1913, with incidents including the theft of its head in 1964 and 1998, the cutting off of its hand in 1984, and the explosion of the statue in 2003.

The statue has also been painted or signed many times, with the most recent incident occurring in 2020 when the inscription 'Racist fish' appeared.

In 2023, the statue was vandalized again with the colors of the Russian flag on its pedestal, which is perceived as a sign of support for the Kremlin in the Ukrainian conflict.

The Danish police have launched an investigation into the latest act of vandalism and are trying to find evidence.

The statue was created by sculptor Edward Eriksen, who was inspired by the main character of the fairy tale by Hans Christian Andersen, and it weighs 175 kg.

The Little Mermaid statue has been decapitated twice, and in 2003, it was knocked off its base with explosives.

In 2017, the statue was doused in red paint as a protest against whale hunting.

In 2020, the words 'racist fish' were painted on the base of the statue during worldwide protests after the death of George Floyd.

The repeated vandalism of the statue may be related to its status as a prominent landmark and symbol of Denmark, making it a target for individuals or groups seeking to make a statement or express dissent.

The motivations behind the vandalism are not explicitly stated, but the Russian flag incident suggests a possible connection to the ongoing conflict in Ukraine.

The Little Mermaid statue is a significant cultural heritage and tourist attraction in Copenhagen, weighing 175 kilograms and created by sculptor Edvard Eriksen.

The statue has been vandalized several times in the past, including burglaries of its head in 1964 and 1998, a severed arm in 1984, and an explosion in 2003 that blew it loose into the bay.

The Copenhagen police have launched an investigation into the vandalism incident and are working to trace the perpetrators.

The Little Mermaid statue in Copenhagen was vandalized with the Russian flag colors, potentially in support of Moscow's position in the Ukraine war.

The vandalism incident may have an impact on tourism, as some tourists were taking pictures of the vandalized statue.

The repeated vandalism incidents may have a negative impact on tourism and the community's perception of the statue and the city.

The statue is an important part of Denmark's cultural heritage, and the vandalism incidents may be seen as an attack on the country's history and identity.

The Little Mermaid statue has been targeted several times since its installation in 1913, including the theft of its head in 1964 and 1998, and the cutting off of its head again in 1998.

In 2003, the statue was damaged by an explosion, and it has also been targeted with graffiti, including an incident in 2020 where it was labeled 'racist fish'.

The vandalism may be related to broader social and political issues, including the ongoing conflict between Russia and Ukraine, and the statue's location on a promenade in Copenhagen makes it a visible target for vandals.

The Russian flag vandalism may be seen as a provocative act, given the current geopolitical tensions, and is perceived as a sign of support for the Kremlin in the Ukrainian conflict.

The Little Mermaid statue in Copenhagen has been vandalized multiple times since its installation 110 years ago, with incidents including the theft of its head, the cutting off of its hand, and the explosion of the statue.

The statue has been decapitated twice, and was knocked off its base with explosives in 2003.

In 2017, the statue was doused in red paint as a protest against whale hunting.

In 2020, the words 'racist fish' were painted on the base of the statue during worldwide protests after the death of George Floyd.

The latest vandalism incident involved painting the Russian flag on the stone the statue sits on, which may be related to Denmark's criticism of Russia's war against Ukraine.

The vandalism incidents may have a negative impact on tourism, as the statue is one of Denmark's most famous landmarks and a popular tourist attraction.

The repeated vandalism may also affect the community's perception of the statue and its cultural significance, potentially leading to a decrease in community pride and ownership.

The incidents may compromise the cultural heritage of the statue, which is a tribute to the Hans Christian Andersen fairy tale and an important part of Danish cultural identity.

The Little Mermaid statue is a famous Danish monument created by sculptor Edward Eriksen, weighing 175 kg, and inspired by the fairy tale of the same name by Hans Christian Andersen.

The vandalism incidents may have a negative impact on tourism, as the statue is a popular tourist attraction and a symbol of Danish culture and heritage.

The repeated vandalism incidents may also affect the community's perception of the statue and its cultural significance, potentially leading to a decrease in community pride and ownership.

The incidents may also have a negative impact on the cultural heritage of Denmark, as the statue is an important part of the country's history and identity.

The Little Mermaid statue in Copenhagen has been vandalized multiple times since its installation in 1913, with incidents including the theft of its head in 1964 and 1998, the cutting off of its hand in 1984, and the explosion of the statue in 2003.

Title:

Content: Danish police investigate who “spoiled ” the famous monument to the Little Mermaid with the colors of the Russian flag
03.03.2023, 7: 15, Misc
Subscribe to Telegram channel
Subscribe to Google News
Support at Patreon
On the pedestal of the famous statue of the Little Mermaid in Copenhagen, a Russian tricolor appeared, says The Guardian.
The Danish police have launched an investigation into such an “act of vandalism ”, which is perceived as a sign of support in the Ukrainian conflict.
AP
In Copenhagen, unknown people painted the foundation of the statue of the Mermaid in Copenhagen in the colors of the Russian flag, writes The Guardian.
According to the publication, the tricolor appeared on Thursday night on the stone, which serves as a pedestal for the famous Danish monument.
The police in Copenhagen said that law enforcement officers visited the crime scene and registered an “act of vandalism ”.
The police began an investigation and are trying to find “evidence ”.
The actions of unknown persons are perceived as a sign of support for the Kremlin in the Ukrainian conflict.
The article notes that the statue of the Little Mermaid weighing 175 kg was created by sculptor Edward Eriksen, who was inspired by the main character of the fairy tale of the same name by Hans Christian Andersen.
The monument suffered from vandals many times: in 1964 her head was stolen, in 1984 her hand was cut off, in 1998 her head was stolen again, but later returned, and in 2003 the statue was blown up.
In addition, the Little Mermaid has been painted or signed many times.
The last time it happened in 2020, when it appeared the mysterious inscription “Racist fish ”, writes The Guardian.
View commentsNo comments
Privacy Policy - GDPR
Site map →
For information cooperation, advertising and publication of ads, write to the address: [email protected]
Support the project:
UMoney- 410011013132383
WebMoney – Z399334682366, E296477880853, X100503068090
18 + © 2002-2022 RYBINSKonLine: All you wanted to know...

The statue has also been painted or signed many times, with the most recent incident occurring in 2020 when the inscription 'Racist fish' appeared.

In 2023, the statue was vandalized again with the colors of the Russian flag on its pedestal, which is perceived as a sign of support for the Kremlin in the Ukrainian conflict.

The Danish police have launched an investigation into the latest act of vandalism and are trying to find evidence.

The statue was created by sculptor Edward Eriksen, who was inspired by the main character of the fairy tale by Hans Christian Andersen, and it weighs 175 kg.

The Little Mermaid statue has been decapitated twice, and in 2003, it was knocked off its base with explosives.

Title:

Content: Russian Flag Painted on Copenhagen's Most Famous Landmark

It's the latest in a long line of attacks on Little Mermaid statue
By Rob Quinn,  Newser Staff
Posted Mar 2, 2023 10:15 AM CST

The Little Mermaid statue in Copenhagen, one of Denmark's most famous landmarks, has been vandalized yet again, this time with the Russian flag. Authorities said Thursday that the white, blue, and red stripes of the Russian flag were painted on the stone the statue sits on, Reuters reports. Police said the vandalism was discovered early Thursday. "We are of course launching an investigation to find out who did it and when and how it happened," a police spokesman said, per Jyllands-Posten.

Denmark, like other European nations, has strongly criticized Russia's war against Ukraine. The small statue, a tribute to the Hans Christian Andersen fairy tale, sits off a waterfront promenade in the Danish capital. It has been vandalized many times since it was installed 110 years ago, AFP reports. It has been decapitated twice and was knocked off its base with explosives in 2003. In 2017, it was doused in red paint in a protest against whale hunting. In 2020, during worldwide protests after the death of George Floyd, the words "racist fish" were painted on the base, though Andersen scholars said they weren't aware of any racist elements in the fairy tale. (Read more The Little Mermaid stories.)

We use cookies. By Clicking "OK" or any content on this site, you agree to allow cookies to be placed. Read more in our privacy policy.
Get the news faster.
Tap to install our app.
X
Install the Newser News app
in two easy steps:
1. Tap in your navigation bar.
2. Tap to Add to Home Screen.

X

In 2017, the statue was doused in red paint as a protest against whale hunting.

In 2020, the words 'racist fish' were painted on the base of the statue during worldwide protests after the death of George Floyd.

The repeated vandalism of the statue may be related to its status as a prominent landmark and symbol of Denmark, making it a target for individuals or groups seeking to make a statement or express dissent.

The motivations behind the vandalism are not explicitly stated, but the Russian flag incident suggests a possible connection to the ongoing conflict in Ukraine.

Title:

Content: Unknown people draw Russian flag on a statue of a mermaid in Copenhagen
COPENHAGEN (AFP) - The iconic Little Mermaid statue in the Danish capital Copenhagen was vandalized on Wednesday night as unidentified people painted the Russian flag on its base.
Announcement
An AFP correspondent reported that the Russian flag was painted under unknown circumstances on the stone above which a statue of the Little Mermaid, inspired by the heroine of one of the stories of the writer Hans Christian Andersen, was installed.
Danish police said they were launching an investigation into the incident, without giving any indication of the source of the move, which shows clear support for Russia amid the ongoing war in Ukraine.
A Copenhagen police spokesman told AFP: "We are investigating the area in order to find any evidence."
A small number of tourists in the area took pictures of the statue in the port of Copenhagen, which was vandalized on Thursday morning.
The Little Mermaid statue on a largely unfrequented promenade has been targeted several times since it was installed in 1913.
In 1964, the head of the nymph was stolen for the first time without being recovered.
In 1998, a group of vandals cut off the head of the statue again, but it was later restored.
This monument was exposed to the explosion in 2003.
The statue, created by Danish sculptor Edvard Eriksen, has also been targeted several times with graffiti or graffiti, most recently in 2020 with the inscription “racist fish ”.

The Little Mermaid statue is a significant cultural heritage and tourist attraction in Copenhagen, weighing 175 kilograms and created by sculptor Edvard Eriksen.

Title:

Content: Danish little mermaid like cornerstone painted Russian flag tricolor
A statue of the Little Mermaid, one of the most iconic tourist attractions in the Danish capital Copenhagen, was deliberately vandalized last night, and the cornerstone below the statue was painted with the white, blue and red colors of the Russian flag.
Advertisement
The Little Mermaid comes from the famous fairy tale of Danish writer Hans Christian Andersen, where the stone beneath the bronze statue is painted in three colors of the Russian flag.
Copenhagen police told Agence France-Presse that since they arrived this morning, "a case of vandalism has been filed" and "local investigations have been launched to trace traces".
It is clear that this means supporting Moscow ’ s position in the Ukraine war.
Some tourists, puzzled by this, took pictures of the damaged statue this morning.
The 175-kilogram Little Mermaid is a work by sculptor Edvard Eriksen, inspired by the Danish poet and writer Hans Christian Andersen ’ s 1837 fairy tale of the same name.
The statue, which sits next to a relatively secluded waterfront walkway, has been vandalized several times over the years, including two burglaries of its head in 1964 and 1998, and a severed arm in 1984. In 2003, the statue was blown loose with explosives and fell into the bay.
It has also been graffitied and painted several times, most recently in 2020 with the words “racist fish. ”

The statue has been vandalized several times in the past, including burglaries of its head in 1964 and 1998, a severed arm in 1984, and an explosion in 2003 that blew it loose into the bay.

The Copenhagen police have launched an investigation into the vandalism incident and are working to trace the perpetrators.

The Little Mermaid statue in Copenhagen was vandalized with the Russian flag colors, potentially in support of Moscow's position in the Ukraine war.

The vandalism incident may have an impact on tourism, as some tourists were taking pictures of the vandalized statue.

The repeated vandalism incidents may have a negative impact on tourism and the community's perception of the statue and the city.

The statue is an important part of Denmark's cultural heritage, and the vandalism incidents may be seen as an attack on the country's history and identity.

The Little Mermaid statue has been targeted several times since its installation in 1913, including the theft of its head in 1964 and 1998, and the cutting off of its head again in 1998.

In 2003, the statue was damaged by an explosion, and it has also been targeted with graffiti, including an incident in 2020 where it was labeled 'racist fish'.

The vandalism may be related to broader social and political issues, including the ongoing conflict between Russia and Ukraine, and the statue's location on a promenade in Copenhagen makes it a visible target for vandals.

The Russian flag vandalism may be seen as a provocative act, given the current geopolitical tensions, and is perceived as a sign of support for the Kremlin in the Ukrainian conflict.

The Little Mermaid statue in Copenhagen has been vandalized multiple times since its installation 110 years ago, with incidents including the theft of its head, the cutting off of its hand, and the explosion of the statue.

The statue has been decapitated twice, and was knocked off its base with explosives in 2003.

In 2017, the statue was doused in red paint as a protest against whale hunting.

The latest vandalism incident involved painting the Russian flag on the stone the statue sits on, which may be related to Denmark's criticism of Russia's war against Ukraine.

The vandalism incidents may have a negative impact on tourism, as the statue is one of Denmark's most famous landmarks and a popular tourist attraction.

The repeated vandalism may also affect the community's perception of the statue and its cultural significance, potentially leading to a decrease in community pride and ownership.

The incidents may compromise the cultural heritage of the statue, which is a tribute to the Hans Christian Andersen fairy tale and an important part of Danish cultural identity.

The Little Mermaid statue is a famous Danish monument created by sculptor Edward Eriksen, weighing 175 kg, and inspired by the fairy tale of the same name by Hans Christian Andersen.

The vandalism incidents may have a negative impact on tourism, as the statue is a popular tourist attraction and a symbol of Danish culture and heritage.

The repeated vandalism incidents may also affect the community's perception of the statue and its cultural significance, potentially leading to a decrease in community pride and ownership.

The incidents may also have a negative impact on the cultural heritage of Denmark, as the statue is an important part of the country's history and identity.